Mithra Pharmaceuticals: Master of financeMithra Pharmaceuticals, a Belgian company focused on women’s health, has appointed Christophe Maréchal as Chief Financial Officer. more ➔
Therachon: Pipeline builderSwiss rare genetic diseases company Therachon AG has named Luca Santarelli Chief Executive Officer and Director. Santarelli brings widespred experience from his role as Venture Partner at Versant Ventures, … more ➔
Morphosys: Driving developmentMalte Peters will leave Sandoz to take over as Chief Development Officer of Morphosys AG. Peters succeeds Arndt Schottelius, who held the position for eight yeara. more ➔
Albumedix: Medical expertiseNovozymes company Albumedix A/S has appointed Giles Campion new Chief Medical Officer. Campion will be in charge of leading the development efforts of the Danish leader in albumin-based drug deliver … more ➔
Newron Pharmaceuticals: Commercial headMilan-based Newron Pharmaceuticals has named Dennis Dionne Vice President Commercial Affairs. Previously, Dionne was Executive Director for Commercial Operations. He replaces Anders Haegerstrand. more ➔
Viiv Healthcare: New at the helmDeborah Waterhouse, currently Senior Vice President Primary Care, GSK US Pharmaceuticals, will take over as CEO of Viiv Healthcare. She succeeds Dominique Limet, who will step down from the post at the … more ➔
Innate Pharma: Change at the topCo-founder of immuno-oncology start-up Innate Pharma Hervé Brailly is making room on the chair of the executive board. His successor Mondher Majhoubi transfers from AstraZeneca, where he was Senior … more ➔
uniQure: From interim to permanentGene therapy company uniQure NV has named Matthew Kapusta its new Chief Executive Officer. Kapusta has been interim CEO since September and also served as Chief Financial Officer for the last two ye … more ➔
BASF: Crew change in health and nutritionAmong other appointments, BASF has named Melanie Maas-Brunner as new President Nutrition and Health, effective April 1, 2017. Previously, Maas-Brunner held the position of Senior Vice President Performance … more ➔
Confo Therapeutics: High calibre chairDrug discovery company Confo Therapeutics has appointed John Edward Berriman as non-executive director and chairman of the board of directors. Berriman is set to take his seat on the board December 21. more ➔
